INSP

55.1002.10%
DG

Dana George Mead

Independent Director

Mr. Dana George Mead, Jr. is Director of BVI Group Limited. He is Independent Chair of the Board of Mobia Medical, Inc. (formerly known as MicroTransponder, Inc.) from November 2025 and is its Director since October 2024. He is Director of Cerapedics, Inc since 2023. He serves as Director since October 2025 at Calyxo, Inc. Mr. Mead, Jr. served as the President, Chief Executive Officer & Director at HeartFlow Inc. from May 2019 to February 2021. He has been the Independent Chairman of Pulmonx Corporation since October 2019 and its Independent Director since February 2010. He had been the Chief Executive Officer and President at Beaver-Visitec International, Inc. from November 14, 2016 to May 2019. Mr. Mead is a Director of Kedalion Therapeutics Inc. He serves as Director of Beaver-Visitec International, Inc. He was Independent Director for Inari Medical, Inc. since October 1, 2021 until its sale to Stryker in February 2025 and Intersect ENT, Inc. from January 2006 until its sale to Medtronic, Inc. in May 2022. He has executive operating experience leading high growth med tech businesses. Mr. Mead served as Strategic Advisor and Partner at Kleiner Perkins Caufield & Byers since May 2005 to June 2016. He joined Kleiner Perkins Caufield & Byers in May 2005 and was responsible for helping identify and grow the firm's portfolio of healthcare companies. He was a part of the life sciences team and focused on pandemic and biodefense investments. He leverages experience gained from his venture-funded, start-up management roles and Board participation to support entrepreneurs and innovators. He served as the President at Vascular Intervention at Guidant Corp. since March 11, 2003 and served as the Vice President of Corporate Relations and Policy until March 11, 2003. He was responsible for Investor Relations, corporate communications, corporate marketing and public policy initiative. He Worked with Guidant Corp in 1992 to 2005, was the President, Guidant Vascular Intervention. Since January 2008. He has experience working with companies across the healthcare space, at various stages of development. He served as the President of Japan and Asia/Pacific at Guidant Corp. from March 2000 to March 2002, the Vice President and General Manager of Stents for Vascular Intervention from 1998 to February 2000, the Vice President and General Manager of Cardiac and Vascular Surgery from 1997 to 1998, the Vice President of Global Marketing of Cardiac and Vascular Surgery through 1997 and a Director of Marketing and Director of Sales at Cardiac and Vascular Surgery from 1994 to 1996. He served in various sales and marketing management roles at Johnson & Johnson Inc. and Allergan Inc. He served as an Executive Officer of Allergan Inc. and Johnson & Johnson. He had been an Independent Director of Intersect ENT, Inc. since June 2007 until 2022. He serves as Executive Director of BVI Audley, Inc. He serves as a Director of Corventis, Inc. ATI, Apnicure, Awarepoint Corporation, Sinexus, Inc. Spiracur Inc. Synvascular, Voyage Medical, Inc. Sonitus, Amigo Therapy and Inspire Medical Systems Inc. since January 2008. He served as a Director of Spinal Modulation, Navigenics, Inc. and Invuity, Inc. He served as an Independent Director at Teladoc, Inc. from August 2011 to December 31, 2016. He served as a Director of Aesthera Corporation since February 22, 2006, OtisMed Corporation, Cardica Inc. and eValve, Inc. He served as a Member of Advisory Board at RWI Ventures. He was Chairman of the Lafayette College West Coast Advisory Council. He serves as a Director of California Life Sciences Association and Lucille Packard Children's Hospital at Stanford University. He was a Director of the Cardiovascular Research Foundation. His career has focused on identifying emerging medical technologies, developing new markets and therapies and building world-class management teams for the last years. Since February 2010, Mr. Mead has served on the Board of Directors of Pulmonx Corporation. He has worked with physician thought leaders around the world representing many different medical specialties. Mr. Mead holds an M.B.A. from the University of Southern California and received a B.A. from Lafayette College.

Positions